nordimet
nordic group b.v. - methotrexate - arthritis, psoriatic, psoriasis, arthritis, juvenile rheumatoid, arthritis, rheumatoid - antineoplastic agents, - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, psoralens and ultraviolet a (puva), and retinoids, and severe psoriatic arthritis in adult patients.
oncaspar
les laboratoires servier - pegaspargase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents, - oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years, and adult patients.,
methotrexate orion pharma 10 mg tablett
methotrexate orion pharma 2,5 mg tablett
lokit capsules
teva pharmaceuticals (pty) ltd - capsules - see ingredients - each capsule contains omeprazole 20,0 mg
injexate 25 mg injektionsvätska, lösning i förfylld injektor
injexate 30 mg injektionsvätska, lösning i förfylld injektor
injexate 22,5 mg injektionsvätska, lösning i förfylld injektor
injexate 17,5 mg injektionsvätska, lösning i förfylld injektor
injexate 15 mg injektionsvätska, lösning i förfylld injektor